drugset / Trial / NCT01263041

Effect of L-arginine and Glutamine on Preterm

NCT01263041

Phase 2/3 Completed 75 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindPrevention

Summary

effects of enteral l-arginine to decrease feeding intolerance and risk of NEC in neonates via its role as a NO precursor. Also, enteral glutamine which may play a role as an immunomodulator on preterm neonates. all these had never been studied in developing countries where sepsis and nec act as a major participant in mortality rates.

Timeline

Start
2011-05
Primary completion
2014-02
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Glutamine Other / unclassified 312 mg/kg Other
Subject L-arginine Small molecule 260 mg/kg Other